Centro Oncológico Internacional (COI)

Guadalajara, Jalisco 45647

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Breast Neoplasms, Neoplasm Metastasis

Studies at this site

• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer — Stopped early